This trial studies whether the nonavalent human papillomavirus vaccine given to adults prior
to kidney transplantation can help the body build and maintain an effective immune response
during the post-transplant period when they receive immunosuppressive drugs to prevent
transplant rejection. This study will help inform our scientific understanding about
vaccine-induced immune responses among immunosuppressed individuals.